Testing effectiveness (Phase 2)Study completedNCT00211315
What this trial is testing
Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Who this might be right for
Coat's Disease
Manhattan Eye, Ear & Throat Hospital 4